Cochlear Ltd

Cochlear Ltd

Cochlear Limited researches, develops and markets cochlear implant systems for hearing impaired individuals. The Company's hearing implant systems include Nucleus and Baha and are sold both domestically and internationally.

Sector Health Technology Sub-Group Medical Specialties
Total Shares 57.43 million Market Cap $8.05 billion
52 week high $159.91 52-week Low $114.48
1-Year Return 9.01% Relative Return (vsXJO) 5.32%
NTA $734.00 million Price/NTA N/A
ROA 20.60% ROE 47.00%
Next Report N/A Next ex-div N/A
Index Member ASX 100, ASX 200, ASX 300, All Ords
Sector Health Technology
Sub-Group Medical Specialties
Total Shares 57.43 million
Market Cap $8.05 billion
52 week high $159.91
52-week Low $114.48
1-Year Return 9.01%
Relative Return (vsXJO) 5.32%
NTA $734.00 million
Price/NTA N/A
ROA 20.60%
ROE 47.00%
Next Report N/A
Next ex-div N/A
Index Member ASX 100, ASX 200, ASX 300, All Ords

Speak to a consultant about
Cochlear Ltd

ENQUIRE NOW

SEARCH FOR COMPANIES

Access our investment insights free

Not understanding the financials of even big blue chips can cost you precious income such as when Telstra reduced their dividends.
This is why our hugely popular Income report has become a must read report for all income investors

Download the Income Report for free to get the top ASX Dividend Stock Recommendations for 2018.

Download Now

We’re here to help

Need to speak to someone about companies or investing?
Our knowledgeable team is on hand to assist